Amygdalin Blocks Bladder Cancer Cell Growth In Vitro by Diminishing Cyclin A and cdk2Jasmina Makarević, Roman A. Blaheta, Jochen Rutz et al.|PLoS ONE|2014Cited by 93
CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot StudyIgor Tsaur, Roman A. Blaheta, Anika Noack et al.|Cancer Research and Treatment|2014Cited by 60
HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin AEva Juengel, Roman A. Blaheta, Iyad Natsheh et al.|Molecular Cancer|2014Cited by 50
Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with <scp>RAD</scp>001 (everolimus) or sorafenibEva Juengel, Roman A. Blaheta, Dana Kim et al.|Journal of Cellular and Molecular Medicine|2014Cited by 29
Cross‐communication between histone H3 and H4 acetylation and Akt‐m<scp>TOR</scp> signalling in prostate cancer cellsJasmina Makarević, Roman A. Blaheta, Nassim Tawanaie et al.|Journal of Cellular and Molecular Medicine|2014Cited by 29